Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours
2002 ◽
Vol 38
(17)
◽
pp. 2272-2278
◽
Keyword(s):
Phase I
◽
2013 ◽
Vol 71
(3)
◽
pp. 647-656
◽
1998 ◽
Vol 34
(7)
◽
pp. 1030-1035
◽
2001 ◽
Vol 84
(5)
◽
pp. 604-610
◽
2004 ◽
Vol 90
(4)
◽
pp. 800-804
◽